Author: Hugman Bruce
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.35, Iss.11, 2012-11, pp. : 1005-1025
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Safety and risk communication to patients
Expert Opinion on Drug Safety, Vol. 5, Iss. 6, 2006-11 ,pp. :
Risk communication in the clinical consultation
By Thomson Richard Edwards Adrian Grey Jenny
Clinical Medicine, Vol. 5, Iss. 5, 2005-09 ,pp. :
Focusing on Risk Communication About Medicines: Why Now?
By Bahri Priya
Drug Safety, Vol. 35, Iss. 11, 2012-11 ,pp. :
Risk communication: the science behind safety warnings
Reactions Weekly, Vol. 1, Iss. 1425, 2012-01 ,pp. :
US FDA lays out strategy for risk communication
Reactions Weekly, Vol. 1, Iss. 1273, 2009-01 ,pp. :